Tissue Diagnostics Market Report by Product Type (Instruments, Consumables), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Others), End-User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and Region 2025-2033

Tissue Diagnostics Market Report by Product Type (Instruments, Consumables), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Others), End-User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1349

Market Overview:

The global tissue diagnostics market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 5.8 Billion
Market Forecast in 2033
USD 9.8 Billion
Market Growth Rate 2025-2033 5.64%


Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.

Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2025-2033. Our report has categorized the market based on product type, technology, disease and end-user.

Breakup by Product Type:

  • Instruments 
  • Consumables
     

Breakup by Technology:

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining
     

Breakup by Disease:

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer
  • Others
     

Breakup by End-User:

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Others
     

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Billion USD
Segment Coverage Product Type, Technology, Disease, End-User, Region
Region Covered North America, Europe, Asia Pacific, Middle East and Africa, Latin America
Companies Covered Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex and Cell Signaling Technology
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global tissue diagnostics market was valued at USD 5.8 Billion in 2024.

We expect the global tissue diagnostics market to exhibit a CAGR of 5.64% during 2025-2033.

The rising adoption of tissue diagnostics in detecting the existence of cancer and analyzing other features that may assist in making disease management decisions is primarily driving the global tissue diagnostics market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cancer treatment procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby negatively impacting the global market for tissue diagnostics.

Based on the product type, the global tissue diagnostics market has been segmented into instruments and consumables, where consumables currently hold the majority of the total market share.

Based on the technology, the global tissue diagnostics market can be divided into immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. Currently, immunohistochemistry exhibits a clear dominance in the market.

Based on the disease, the global tissue diagnostics market has been categorized into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and others. Among these, breast cancer currently accounts for the largest market share.

Based on the end-user, the global tissue diagnostics market can be segregated into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and others. Currently, hospitals exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global tissue diagnostics market include Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Tissue Diagnostics Market Report by Product Type (Instruments, Consumables), Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Others), End-User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials